Vortrag am FONDS professionell KONGRESSUBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD
| MVD-Fonds Rating | EDA |
|---|---|
  | 75 |
ISIN: LU0069152568 | WKN: 986327
KAG: UBS Fund M. (LU)
NAV: 764,58 USD am 21.08.2024
Portfolio
Watchlist
KursalarmChart
Kennzahlen UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | -0,43% | +11,90% | +14,07% | -10,12% | +32,80% | +57,51% | +664,58% |
| Volatilität | +20,16% | +19,33% | +20,31% | +22,14% | +23,89% | +24,59% | +27,20% |
| Sharpe Ratio | -0,43 | +1,13 | +0,52 | -0,32 | +0,10 | +0,05 | +0,15 |
| Bester Monat | - | +9,18% | +15,82% | +15,82% | +15,82% | +15,82% | +41,13% |
| Schl. Monat | - | -8,43% | -8,90% | -11,66% | -11,66% | -21,18% | -28,27% |
| Max. Verlust | -7,92% | -11,41% | -15,39% | -36,37% | -36,37% | -40,97% | -75,23% |
Monatsperformance UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD
| 2024 | 2023 | 2022 | 2021 | 2020 | |
| Januar | -2,87% | +1,32% | -11,66% | -0,85% | -3,79% |
| Februar | -0,65% | -6,03% | -2,71% | -3,31% | +0,14% |
| März | +1,77% | +0,80% | +4,10% | -2,99% | -6,99% |
| April | -8,43% | +0,63% | -9,90% | +2,18% | +14,55% |
| Mai | +9,18% | -2,75% | -3,91% | -1,47% | +10,01% |
| Juni | +3,78% | +1,04% | +5,86% | +9,09% | +3,09% |
| Juli | +6,78% | +2,67% | +1,43% | -1,56% | -2,92% |
| August | -2,00% | -2,00% | +5,19% | +5,14% | -0,79% |
| September | - | -4,14% | -0,31% | -6,32% | +0,08% |
| Oktober | - | -8,90% | +4,72% | -3,03% | -4,94% |
| November | - | +5,02% | +6,94% | -4,24% | +10,70% |
| Dezember | - | +15,82% | -6,14% | +2,61% | +5,51% |
| Gesamt | +6,63% | +1,42% | -8,32% | -5,64% | +24,59% |
